ZW191: Connecting ADC Preclinical Performance Insights to Clinical Potential

• Introducing the in-depth preclinical profile of ZW191 targeting FRα
• Understanding how the design elements of ZW191 manifested in preclinical performance
• Looking ahead: Anticipating clinical impact and outcomes based on reported preclinical activity

Speakers:

Stuart Barnscher

Senior Director, Preclinical Programs, Adc Therapeutic Development

Zymeworks